The Moderna ($MRNA) Mystery: Why Location Beats News Every Single Time

Why is Moderna ($MRNA) suddenly waking up after being left for dead? Is it a new vaccine narrative? A “COVID-20” rumour? Earnings? If you’re scouring the headlines for an answer, you’re looking in the completely wrong place. I’ll let you in on a secret: The news is just the noise that follows the move. In...

How Big Timeframe Supply and Demand Imbalances Move the Markets

Most traders are fighting over five-minute candles like pigeons over a dropped sandwich. Meanwhile, the real decisions are being made on yearly and quarterly charts that almost nobody even opens. Today, I’m breaking down Moderna (NASDAQ: MRNA) and showing you how a 12-month demand imbalance at $29.79 stopped the decline after years of lower prices....

Moderna stock pharmaceuticals stock reacting to strong imbalances

Moderna stock MRNA pharmaceutical has started to react to the strong weekly imbalance mentioned in the last update. This biotech company is distributing one of the approved coronavirus vaccines to millions of people around the world. Is Moderna stock MRNA a stock to buy? It definitely has been, as explained in the last Moderna stock...

Moderna stock pharmaceuticals stock. Is it a buy?

We might think that Moderna stock pharmaceuticals could be subject to wild swings as this biotech company is attempting to distribute a coronavirus vaccine to millions worldwide. Is Moderna stock MRNA a stock to buy? Moderna stock has been a stock to buy quite a few times in the last few months. As supply and...

Moderna Biotech stock forecast and coronavirus Covid-19

The big story in biotechnology this past week has been the rise and fall of Moderna Biotechnology (mRNA) stock. As explained in a previous Moderna Inc Biotechnology stock longs 2020 post for the weekly timeframe a few days ago, we were expecting Moderna Biotech (MRNA) to retrace to a weekly imbalance of around $20, and...

Moderna Inc Biotechnology stock longs 2020

Moderna Biotechnology (mRNA) is a clinical-stage biotechnology company that develops therapeutics and vaccines based on messenger RNA for treating infectious diseases, immuno-oncology, rare diseases, and cardiovascular diseases. As of February 15, 2019, the company had 11 clinical trials programs and 20 development candidates in six modalities comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative...

Recent Posts

forex intraday trading and scalping
stop trading every day

Free Trade Ideas

Weekly trade ideas based on real supply & demand.
No indicators, no guessing.

Real examples shared publicly on YouTube.

0